NDC11 50228034010
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50228-0340-10 | 50228-0340 |
| 50228-340-10 | 50228-340 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | ScieGen Pharmaceuticals, Inc. | f15664a4-6b5f-4e88-ad56-c827ed90a40c | 2021-01-08 | Boxed warning, Warnings, Adverse reactions | 50228-340-10 50228-340 50228034010 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.